Telma CT 40/6.25 mg Tablet

Telma CT 40/6.25mg tablet is a prescription based medication that is used to control high blood pressure in adults. The medication contains two active ingredient is Telmisartan in (40mg) concentration and Chlorthalidone in (6.25mg) concentration.

It belongs to the drug class of antihypertensive, specifically a combination of angiotensin II receptor blocker (ARB). The medicine works by relaxing blood vessels and removing excess salt and water from the body.

Thereby, helping to lower blood pressure and improve overall cardiovascular health by reducing strain on the heart. The dosage and duration should be strictly followed as prescribed by the healthcare professional.

Manage high blood pressure

Telma CT 40/6.25mg tablet also causes various side effects, some are acute and some are mild. Always consult a healthcare professional before using any medication to ensure safe and effective treatment.

Reach out to the doctor if any of the symptoms persist or worsen:

• Dizziness

• Headache

• Fatigue

• Increased urination

• Muscle cramps or weakness

• Low blood pressure symptoms

• Allergic reactions (e.g., swelling of the face, lips, tongue, or throat, difficulty breathing, rash)

• Severe dizziness

• Light headedness

• Fainting

• High potassium levels (muscle weakness, irregular heartbeat)

• Liver problems

• Dose must be administered by healthcare professional only. Do not continue to the medication if any of the side effects persist. Taken Telma CT 40/6.25mg tablet with food or without food at the fixed time everyday to enhance the effectiveness of the medication.
• Do not crush, chew or break the tablet as this may affect the way the medicine works and increase the side effects.​
  

• Telma CT 40/6.25mg tablet contains two salts Telmisartan (40mg) and Chlorthalidone (625mg). Telmisartan and widens blood vessels, making it easier for blood to flow and the heart to pump.
• Chlorthalidone increases urine output which reduces fluid volume in the body and lowering blood pressure further. They work together and reduces strain on the heart and can help lower the risk of complications like heart attack and stroke.​
  

• Pareek, A., Karnik, N., Salagre, S. B., Zawar, S. D., Joglekar, V. K., Chandurkar, N., & Naik, G. S. (2008). Clinical effectiveness of low-dose chlorthalidone (6.25 mg)+ atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Current medical research and opinion, 24(6), 1771-1779. https://pubmed.ncbi.nlm.nih.gov/18479589/

• Pareek, A., Basavanagowdappa, H., Zawar, S., Kumar, A., & Chandurkar, N. (2009). A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension. Expert Opinion on Pharmacotherapy, 10(10), 1529-1536. https://pubmed.ncbi.nlm.nih.gov/19514864/

• Pareek, A., Zawar, S. D., Salagre, S. B., Chandurkar, N. B., & Karnik, N. D. (2009). Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in Indian patients with mild-to-moderate essential hypertension. European journal of medical research, 14(7), 297. https://pmc.ncbi.nlm.nih.gov/articles/PMC3458640/

• Carter, B. L., Ernst, M. E., & Cohen, J. D. (2004). Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension, 43(1), 4-9. https://pubmed.ncbi.nlm.nih.gov/14638621/

• Sekhar, V. (2021). METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF CHLORTHALIDONE IN BULK AND TABLET DOSAGE FORM BY UV SPECTROPHOTOMETRY.